Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Phosducin-like protein is a putative modulator of heterotrimeric G proteins. Zusätzlich bieten wir Ihnen Phosducin-Like Proteine (7) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 39 products:
Human Polyclonal PDCL Primary Antibody für WB - ABIN1944777
Wiemann, Weil, Wellenreuther, Gassenhuber, Glassl, Ansorge, Böcher, Blöcker, Bauersachs, Blum, Lauber, Düsterhöft, Beyer, Köhrer, Strack, Mewes, Ottenwälder, Obermaier, Tampe, Heubner, Wambutt, Korn et al.: Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. ... in Genome research 2001
Zeige alle 3 Referenzen für ABIN1944777
Phosducin (zeige PDC Antikörper) regulates secretory activity in TT line of thyroid parafollicular C cells.
PhLP1 binding stabilizes the Gbeta (zeige SUCLG2 Antikörper) fold, disrupting interactions with CCT (zeige FLVCR2 Antikörper) and releasing a PhLP1-Gbeta (zeige SUCLG2 Antikörper) dimer for assembly with Ggamma.
evidence of a generic mechanism, whereby the splicing of the PhLP gene could potentially and efficiently regulate the cellular levels of heterotrimeric G proteins.
Data suggest that phosducin (zeige PDC Antikörper) rs12402521 polymorphism is an important genetic predictor of obesity-related hypertension.
identification of Pdc (zeige PNKD Antikörper) as a gene for stress-induced hypertension offers new insights into the relationship between sympathetic nervous system activation, blood pressure regulation and genetic factors
Data suggest that the existence of a common epitope on the molecules of phosducin (zeige PDC Antikörper) and beta-actin (zeige ACTB Antikörper) may reflect a topological similarity of a small region of their surfaces.
Candidate gene-based association studies in 2 different populations revealed several SNPs in the PDC (zeige PNKD Antikörper) gene to be associated with stress-dependent blood pressure phenotypes.
Phosducin (zeige PDC Antikörper) mutations are not a major cause of dominant or recessive retinitis pigmentosa, Leber congenital amaurosis, or cone-rod degeneration.
SUMO-1 (zeige SUMO1 Antikörper) controls the protein stability and the biological function of phosducin (zeige PDC Antikörper).
physiological control of G-protein regulation by PhLP seems to involve phosphorylation by CK2 (zeige CSNK2A1 Antikörper) and alternative splicing of the regulator
findings reveal a common mechanism of Gbetagamma and RGS9-Gbeta5 assembly in rods and cones, highlighting the importance of PhLP1 and CCT-mediated Gbeta complex formation in G protein signaling.
this study demonstrated in vivo that PhLP1 is required for the folding and assembly of both Gbetagamma and Gbeta5-RGS9.
These data are consistent with the hypothesis that PhLP is a widely expressed modulator of Gbetagamma function.
These results suggest a mechanism for Gbetagamma assembly in which PhLP stabilizes the nascent Gbeta (zeige SUCLG2 Antikörper) polypeptide until Ggamma can associate, resulting in membrane binding of Gbetagamma and release of PhLP to catalyze another round of assembly.
N-glycosylated phosducin-like protein long (PhLP(L)) is expressed in all structures of the central nervous system and regulates opioid receptor function in the brain.
identification of novel germ-like specific form in phosducin-like protein family
antagonistic actions of PhLP3 and prefoldin serve to modulate CCT activity and play a key role in establishing a functional cytoskeleton in vivo
Phosducin-like protein is a putative modulator of heterotrimeric G proteins. The protein shares extensive amino acid sequence homology with phosducin, a phosphoprotein expressed in retina and pineal gland. Both phosducin-like protein and phosphoducin have been shown to regulate G-protein signaling by binding to the beta-gamma subunits of G proteins.
, 33 kDa phototransducing protein
, G beta gamma binding protein
, phosducin-like orphan protein
, phosducin-like protein